Oral rinse, nasal spray and methods for prevention of COVID-19 by lowering viral load of COVID-19
AssigneeRucker Capital Advisors
InventorKeith D. Crawford
Life of this patent
Estimating the term…
Abstract
Compositions and methods are provided for a nasal spray or mouthwash formulation for prevention and amelioration of disease progression caused by a virus infection, the formulation including: an algae derivative; and a buffer. The method effectively bathes the mouth and throat tissues to decrease COVID-19 concentration and functionality; thereby preventing growth and spread of the virus and lower the viral load present in the lungs and in GI tract.
Claims25
-32. (canceled)
A method for preventing a viral particle of a virus from entering a host cell on a mucosal membrane of a subject by decreasing a viral load of the virus, the method comprising:
- administering in a protocol of applying a polyinterferent composition, the composition comprising povidone iodine, iota carrageenan, thymol, eucalyptol, menthol, methyl salicylate, ethanol, and an acceptable buffer, to the mucosal membrane of the subject.
-48. (canceled)
-55. (canceled)
A method for preventing a viral particle of a SARS-COV-2 virus from entering a host cell on a mucosal membrane of a subject by decreasing viral inoculum, the method comprising:
- administering a chewing gum comprising an exterior surface encasing a liquid polyinterferent composition, the composition comprising iota carrageenan, thymol, eucalyptol, menthol, methyl salicylate, ethanol, and an acceptable buffer;
- breaking the exterior surface of the chewing gum by the subject biting the chewing gum to release the liquid polyinterferent composition into an oral cavity of the subject;
- gargling mouth and throat of the subject by contacting deep throat mucosal membranes with the polyinterferent composition;
- and
- expectorating the polyinterferent composition thereby decreasing viral load in the subject.
(canceled)
-64. (canceled)
A kit for preventing a viral particle from entering a host cell on a mucosal membrane of a subject by decreasing a viral load, the kit comprising:
- a mouthwash comprising a polyinterferent composition comprising iota-carrageenan, sodium chloride, xylitol, benzyl alcohol, potassium sorbate, citric acid, and an acceptable buffer;
- a nasal rinse comprising an algal derivative, a salt, and at least one excipient;
- and
- instructions for use.
Dependencies are inferred from the claim text.